Ganz, Patricia A. http://orcid.org/0000-0002-1841-4143
Bandos, Hanna
Geyer, Charles E. Jr.
Robidoux, André
Paterson, Alexander H. G.
Polikoff, Jonathan
Baez-Diaz, Luis
Brufsky, Adam M.
Fehrenbacher, Louis
Parsons, Ann W.
Ward, Patrick J.
Provencher, Louise
Hamm, John T.
Stella, Philip J.
Carolla, Robert L.
Margolese, Richard G.
Shibata, Henry R.
Perez, Edith A.
Wolmark, Norman
Clinical trials referenced in this document:
Documents that mention this clinical trial
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer
https://doi.org/10.1007/s10549-021-06475-2
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)
https://doi.org/10.1007/s10549-021-06417-y
Funding for this research was provided by:
national cancer institute (U10CA180868, U10CA44066)
national cancer institute (UG1CA189867, UG1CA180822)
pharmacia & upjon
Article History
Received: 13 August 2021
Accepted: 2 December 2021
First Online: 3 February 2022
Declarations
:
: Charles E. Geyer, Jr.—Grants, non-financial support and other from Genentech/Roche, Daiichi/Sankyo, and AstraZeneca, during the conduct of the study, and personal fees from Exact Sciences and Athenex, outside the submitted work. Johnathan Polikoff—Consultant, Natera. Louis Provencher—Consulting or Advisory Role: Lilly, Pfizer, Roche, and Novartis. Research Funding: Pfizer, Roche, Novartis, Merck, GlaxoSmithKline, and Odonate Therapeutics. The remaining authors declare no conflicts of interest.
: The protocol was approved by institutional IRBs. All studies involving human participants are in accord with ethical standards of the institutional research board and the Helsinki declaration or comparable ethical standards.
: The study was approved by the local institutional review board. Written informed consent was required of all participants.
: All authors have consented for publication.